Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads

View ORCID ProfileDebra Van Egeren, View ORCID ProfileMadison Stoddard, Abir Malakar, Debayan Ghosh, Antu Acharya, Sk Mainuddin, Biswajit Majumdar, Deborah Luo, Ryan Nolan, View ORCID ProfileDiane Joseph-McCarthy, View ORCID ProfileLaura F. White, View ORCID ProfileNatasha S. Hochberg, View ORCID ProfileSaikat Basu, View ORCID ProfileArijit Chakravarty
doi: https://doi.org/10.1101/2022.03.25.22272956
Debra Van Egeren
1Weill Cornell Medicine, New York, NY, USA
2New York Genome Center, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Debra Van Egeren
Madison Stoddard
3Fractal Therapeutics, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Madison Stoddard
Abir Malakar
4South Dakota State University, Brookings, SD, USA
5Jadavpur University, Kolkata, WB, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debayan Ghosh
5Jadavpur University, Kolkata, WB, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antu Acharya
5Jadavpur University, Kolkata, WB, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sk Mainuddin
5Jadavpur University, Kolkata, WB, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Biswajit Majumdar
5Jadavpur University, Kolkata, WB, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Luo
6Amity Regional High School, Woodbridge, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Nolan
7Halozyme Therapeutics, San Diego, CA, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Joseph-McCarthy
8Boston University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diane Joseph-McCarthy
Laura F. White
8Boston University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura F. White
Natasha S. Hochberg
9Boston University School of Medicine, Boston, MA, USA
10Boston Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natasha S. Hochberg
Saikat Basu
4South Dakota State University, Brookings, SD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Saikat Basu
Arijit Chakravarty
3Fractal Therapeutics, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arijit Chakravarty
  • For correspondence: arijit@fractaltx.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

In the face of a long-running pandemic, understanding the drivers of ongoing SARS-CoV-2 transmission is crucial for the rational management of COVID-19 disease burden. Keeping schools open has emerged as a vital societal imperative during the pandemic, but in-school transmission of SARS-CoV-2 can contribute to further prolonging the pandemic. In this context, the role of schools in driving SARS-CoV-2 transmission acquires critical importance. Here we model in-school transmission from first principles to investigate the effectiveness of layered mitigation strategies on limiting in-school spread. We examine the effect of masks and air quality (ventilation, filtration and ionizers) on steady-state viral load in classrooms, as well as on the number of particles inhaled by an uninfected person. The effectiveness of these measures in limiting viral transmission is assessed for variants with different levels of mean viral load (Wuhan, Delta, Omicron). Our results suggest that a layered mitigation strategy can be used effectively to limit in-school transmission, with certain limitations. First, poorly designed strategies (insufficient ventilation, no masks, staying open under high levels of community transmission) will permit in-school spread even if some level of mitigation is ostensibly present. Second, for viral variants that are sufficiently contagious, it may be difficult to construct any set of interventions capable of blocking transmission once an infected individual is present, underscoring the importance of other measures. Our findings provide several practical recommendations: the use of a layered mitigation strategy that is designed to limit transmission, with other measures such as frequent surveillance testing and smaller class sizes (such as by offering remote schooling options to those who prefer it) as needed.

Competing Interest Statement

A.C. and M.S. are employees of Fractal Therapeutics. R.N. is an employee of Halozyme Therapeutics. A.C., M.S., R.N., D.V.E., and D.J.-M. are shareholders in Fractal Therapeutics.

Funding Statement

This material is based upon work partially supported by the National Science Foundation (NSF) RAPID Grant 2028069 for COVID-19 research, with SB as the Principal Investigator. Any opinions, findings, and conclusions or recommendations expressed here are, however, those of the author and do not necessarily reflect NSF's views. Fractal Therapeutics provided salary support for author M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Airborne viral concentration simulation data are reproducible using the code available at https://github.com/dvanegeren/covid-indoor-transmission. All additional data are available from the authors upon reasonable request.

https://github.com/dvanegeren/covid-indoor-transmission

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted March 31, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
Debra Van Egeren, Madison Stoddard, Abir Malakar, Debayan Ghosh, Antu Acharya, Sk Mainuddin, Biswajit Majumdar, Deborah Luo, Ryan Nolan, Diane Joseph-McCarthy, Laura F. White, Natasha S. Hochberg, Saikat Basu, Arijit Chakravarty
medRxiv 2022.03.25.22272956; doi: https://doi.org/10.1101/2022.03.25.22272956
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
Debra Van Egeren, Madison Stoddard, Abir Malakar, Debayan Ghosh, Antu Acharya, Sk Mainuddin, Biswajit Majumdar, Deborah Luo, Ryan Nolan, Diane Joseph-McCarthy, Laura F. White, Natasha S. Hochberg, Saikat Basu, Arijit Chakravarty
medRxiv 2022.03.25.22272956; doi: https://doi.org/10.1101/2022.03.25.22272956

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (240)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1420)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
  • Epidemiology (10297)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2629)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1733)
  • Health Policy (789)
  • Health Systems and Quality Improvement (673)
  • Hematology (266)
  • HIV/AIDS (565)
  • Infectious Diseases (except HIV/AIDS) (12093)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (289)
  • Neurology (2461)
  • Nursing (145)
  • Nutrition (377)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1324)
  • Ophthalmology (401)
  • Orthopedics (146)
  • Otolaryngology (237)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (780)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2397)
  • Public and Global Health (5007)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (528)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (245)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)